QA: Trisalus Life Sciences Inc in us_health_services/2024

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001826667_2025_Trisalus_Life_Sciences_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001826667, Trisalus Life Sciences Inc

  xvar xval
0 IntangibleAssets 0
1 AssetsNonCurrent 1,633,000
2 AssetsCurrent 20,669,000
3 PropertyPlantAndEquipment 1,669,000
4 remainder_Assets 0
5 LongTermLiabilities 22,084,000
6 LiabilitiesCurrent 10,228,000
7 remainder_Liabilities 17,553,000
8 LaborExpense 0
9 CostOfGoodsAndServicesSold 4,103,000
10 GeneralAndAdministrativeExpense 17,966,000
11 GoodwillImpairmentLoss 0
12 OperatingCostsAndExpenses 0
13 DepreciationDepletionAndAmortization 0
14 SellingAndMarketingExpense 25,839,000
15 ResearchAndDevelopmentExpense 17,688,000
16 remainder_Expenses -8,135,000
17 remainder_Revenues 29,431,000
18 remainder_NetIncome -2,015,000
19 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 23,971,000
1 Liabilities 49,865,000
2 Expenses 57,461,000
3 Revenues 29,431,000
4 StockholdersEquity -25,894,000
5 NetIncome -30,045,000
6 ComprehensiveNetIncome -30,045,000
7 BaseVar 81,371,500
8 EconomicCapitalRatiobeforeLimitedLiability -1.83
9 EconomicCapitalRatio 0.435

Edgar->Model Mapping

Feature Distribution

Change over Time